Jan 12 (Reuters) - Acasti Pharma Inc ACST.V
* Acasti Pharma reports third quarter 2017 financial results
* Q3 loss per share C$0.22
* Acasti pharma - Had cash,short-term investments of $5.8 million as of Nov 30, 2016
* Acasti Pharma - if co doesn't raise additional funds, there exists material uncertainty casting substantial doubt about ability to continue as going concern Source text for Eikon: Further company coverage: ACST.V